Initial clinical evaluation of chest digital tomosynthesis in adult patients with COVID-19 pneumonia

Zhanxia Li,Xiuhua Wu,Guobin Zhang,Dianliang Wu,Yunjiao Zhang,Chengji Wang,Lumin Zou,Xiaohua Gu,Tao Ren
DOI: https://doi.org/10.1097/cm9.0000000000003297
IF: 6.133
2024-09-21
Chinese Medical Journal
Abstract:To the Editor : The coronavirus disease 2019 (COVID-19) pandemic has caused a significant global health crisis, led to staggering mortality rates, and imposed a substantial economic burden. [ 1 ] Pneumonia is the leading cause of mortality in patients with COVID-19. During outbreak peaks, the surge in patients severely strained healthcare systems, highlighting the need for rapid and cost-effective screening methods. Although chest X-ray (CXR) is affordable and convenient, its low sensitivity limits its effectiveness for detecting lung abnormalities. Computed tomography (CT) is considered the gold standard for diagnosing pneumonia, including COVID-19 pneumonia, but it exposes patients to high doses of radiation (3–7 mSv) far exceeding the annual threshold of 1 mSv recommended by the World Health Organization. Even low-dose CT delivers an average effective dose of 1.6 mSv, adding to the patient's radiation burden. [ 2 ]
medicine, general & internal
What problem does this paper attempt to address?